Beauty Farm Medical and Health Industry Inc. repurchased 25,000 ordinary shares on 24 April 2026 via the Hong Kong Stock Exchange, paying an aggregate HKD 0.52 million at prices between HKD 20.72 and HKD 21.00 per share.

Following the transaction: • Issued shares outstanding (excluding treasury shares) declined 0.01 % to 249.96 million. • Treasury shares increased to 1.63 million, while total issued shares remained unchanged at 251.59 million. • The repurchased shares will be held in treasury; no cancellation has been announced.

The buyback was executed under the mandate granted on 27 June 2025, which authorises the company to repurchase up to 23.58 million shares. To date, 1.63 million shares have been bought back, representing 0.69 % of the issued share base when the mandate was approved.

A 30-day moratorium on new share issues or sales of treasury shares applies until 24 May 2026, in line with Hong Kong listing rules.